Monday, November 16, 2026
News

COVID-19 vaccination for children: CDSCO approved ZyCoV-D for restricted use in emergency situations

SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | November 30, 2021 10:49:32 PM IST
The Interim Phase II, III clinical trial data of COVAXIN on Healthy Volunteers aged 2 to 18 years submitted by Bharat Biotech was deliberated in the meeting of the Subject Expert Committee (SEC) on August 28 and October 11, informed Ministry of Health and Family Welfare.

The Union Minister of State for Health and Family Welfare, Dr Bharati Pravin Pawar stated this in a written reply in the Rajya Sabha.

The committee recommended for grant of market authorization for the age group of 2 to 18 years for Restricted Use in Emergency Situation subject to various conditions. This recommendation is being examined and additional information has been requested at the level of the Central Drugs Standard Control Organisation (CDSCO).

CDSCO has also approved the COVID-19 vaccine (ZyCoV-D) of M/s Cadila Healthcare for restricted use in an emergency situation in the age group 12 years and above. (ANI)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Love beyond borders: Hosur pilot ties th...
'Suvendu Adhikari following Yogi Adityan...
Cauvery water shortage leaves devotees d...
'Theatre Commands are operational impera...
'Ye sab galat hai...': CDS General NS Ra...
'May everyones prayers be answered': Ra...
More...    
 
 Top Stories
India's unemployment rate falls to ... 
This nation has more Earthshot Priz... 
Chai Kaapi Introduces ESOPs for Emp... 
BCCI congratulates Jay Shah on his ... 
Tommy Hilfiger hits the road with R... 
One in five pregnant, lactating wom... 
"Intentionally or unintentionally, ... 
Jaya and Santhosh Are Helping a New...